Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 2 1Phase 1 1

Status

Completed 4Withdrawn 2Terminated 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 3NIH 1

Study Type

Interventional 4Observational 3

Sponsor

Cancer Type

Gastrointestinal 3Genitourinary 1

Conditions

Carcinoma, Hepatocellular 3Prostatic Neoplasms 1Liver Neoplasms 1

Interventions

Cyclophosphamide 1492Cisplatin 1414Paclitaxel 1317Radiotherapy 1261Carboplatin 1250Gemcitabine 1215Docetaxel 1109Bevacizumab 1030Fluorouracil 894Doxorubicin 792Dexamethasone 748Rituximab 719Capecitabine 716Oxaliplatin 700pembrolizumab 680Etoposide 678Irinotecan 634Filgrastim 621Cytarabine 586Leucovorin 579Nivolumab 558Vincristine 515Prednisone 475Cetuximab 465Bortezomib 459Erlotinib Hydrochloride 456Trastuzumab 447Methotrexate 438Lenalidomide 427Pemetrexed 420

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Interventional × gadolinium ethoxybenzyl DTPA × Clear all
NCT04288323 2026-02-12

Gadolinium Contrast-enhanced Abbreviated MRI (AMRI) vs. Standard Ultrasound for Hepatocellular Carcinoma (HCC) Surveillance in Patients With Cirrhosis

University of California, San Diego

Phase 4 Completed
79 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT01867424 2020-07-08

Gadoxetate Enhanced Imaging Study to Detect Prostate Cancer

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
24 enrolled 11 charts
Genitourinary

Prostatic Neoplasms

NCT01575574 2016-08-23

PRIGA

Fundacion Clinic per a la Recerca Biomédica

Phase 4 Completed
74 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT02578602 2015-10-19

MRI With Gadoxetate Disodium in Measuring Tumors in Patients With Liver Cancer

University of Southern California

Phase 1 Completed
26 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡